Demerger

Jeffrey Ubben will be the first shareholder activist to join Bayer's Supervisory Board if the vote goes as expected at the AGM on April 26. The proxy advisors have no objections to his appointment.

Following its demerger from the Fresenius Group, dialysis specialist Fresenius Medical Care (FMC) is stepping up its efforts to reduce costs and streamline its portfolio. The MDax company is also aiming to make significant gains in its operating performance in the current year.